Alphina Therapeutics, Inc.
Biotechnology · New Haven, CT
BiotechnologySEC Form D
Alphina Therapeutics, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 16, 2026, reporting $153,715 raised toward a $10,000,000 offering.
Incorporated in Delaware and based in New Haven, CT, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Alphina Therapeutics, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Nicholas J GalliExecutive Officer · Director
- Ranjit BindraDirector
- Kevin RakinDirector
- Colleen CuffaroDirector
- Barbara FoxExecutive Officer · Director
- Matthew CohenDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$1.6MRaised